498 related articles for article (PubMed ID: 12634356)
41. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.
Planelles V; Bachelerie F; Jowett JB; Haislip A; Xie Y; Banooni P; Masuda T; Chen IS
J Virol; 1995 Sep; 69(9):5883-9. PubMed ID: 7637036
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
43. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.
Zhu Y; Gelbard HA; Roshal M; Pursell S; Jamieson BD; Planelles V
J Virol; 2001 Apr; 75(8):3791-801. PubMed ID: 11264368
[TBL] [Abstract][Full Text] [Related]
44. Insights into the biology of HIV-1 viral protein R.
Sherman MP; De Noronha CM; Williams SA; Greene WC
DNA Cell Biol; 2002 Sep; 21(9):679-88. PubMed ID: 12396611
[TBL] [Abstract][Full Text] [Related]
45. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species.
Brussel A; Sonigo P
J Virol; 2004 Oct; 78(20):11263-71. PubMed ID: 15452245
[TBL] [Abstract][Full Text] [Related]
46. The second chance story of HIV-1 DNA: Unintegrated? Not a problem!
Wu Y
Retrovirology; 2008 Jul; 5():61. PubMed ID: 18613958
[TBL] [Abstract][Full Text] [Related]
47. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation.
Stewart SA; Poon B; Song JY; Chen IS
J Virol; 2000 Apr; 74(7):3105-11. PubMed ID: 10708425
[TBL] [Abstract][Full Text] [Related]
48. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.
Haffar OK; Popov S; Dubrovsky L; Agostini I; Tang H; Pushkarsky T; Nadler SG; Bukrinsky M
J Mol Biol; 2000 Jun; 299(2):359-68. PubMed ID: 10860744
[TBL] [Abstract][Full Text] [Related]
49. Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap.
Limón A; Nakajima N; Lu R; Ghory HZ; Engelman A
J Virol; 2002 Dec; 76(23):12078-86. PubMed ID: 12414949
[TBL] [Abstract][Full Text] [Related]
50. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.
Depienne C; Roques P; Créminon C; Fritsch L; Casseron R; Dormont D; Dargemont C; Benichou S
Exp Cell Res; 2000 Nov; 260(2):387-95. PubMed ID: 11035935
[TBL] [Abstract][Full Text] [Related]
51. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
52. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.
Kobinger GP; Borsetti A; Nie Z; Mercier J; Daniel N; Göttlinger HG; Cohen A
J Virol; 1998 Jul; 72(7):5441-8. PubMed ID: 9620999
[TBL] [Abstract][Full Text] [Related]
53. Viral complementation allows HIV-1 replication without integration.
Gelderblom HC; Vatakis DN; Burke SA; Lawrie SD; Bristol GC; Levy DN
Retrovirology; 2008 Jul; 5():60. PubMed ID: 18613957
[TBL] [Abstract][Full Text] [Related]
54. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
Wang L; Mukherjee S; Jia F; Narayan O; Zhao LJ
J Biol Chem; 1995 Oct; 270(43):25564-9. PubMed ID: 7592727
[TBL] [Abstract][Full Text] [Related]
55. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
[TBL] [Abstract][Full Text] [Related]
56. HIV-1 viral protein R (Vpr) as a regulator of the target cell.
Ayyavoo V; Rafaeli Y; Nagashunmugam T; Mahalingham S; Phung MT; Hamam A; Williams WV; Weiner DB
Psychoneuroendocrinology; 1997; 22 Suppl 1():S41-9. PubMed ID: 9264146
[TBL] [Abstract][Full Text] [Related]
57. Packageable antiviral therapeutics against human immunodeficiency virus type 1: virion-targeted virus inactivation by incorporation of a single-chain antibody against viral integrase into progeny virions.
Okui N; Sakuma R; Kobayashi N; Yoshikura H; Kitamura T; Chiba J; Kitamura Y
Hum Gene Ther; 2000 Mar; 11(4):537-46. PubMed ID: 10724032
[TBL] [Abstract][Full Text] [Related]
58. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.
Singh SP; Tungaturthi P; Cartas M; Tomkowicz B; Rizvi TA; Khan SA; Kalyanaraman VS; Srinivasan A
Virology; 2001 Apr; 283(1):78-83. PubMed ID: 11312664
[TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.
Kino T; Gragerov A; Slobodskaya O; Tsopanomichalou M; Chrousos GP; Pavlakis GN
J Virol; 2002 Oct; 76(19):9724-34. PubMed ID: 12208951
[TBL] [Abstract][Full Text] [Related]
60. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
